Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 5/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 3/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 6/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9549683 | 0.89 | ESR1 (0.39) | ALOX5ALOX12ALDH1A1 | |
| SCHEMBL10587272 | 0.82 | TYR (0.43) | ALOX12ALDH1A1SMN1; SMN2 | |
| SCHEMBL10670145 | 0.79 | ACHE (0.44) | CHRNA7ACHETDP1ALOX5STAT3 | |
| SCHEMBL8750364 | 0.79 | CHRNA7 (0.50) | CHRNA7ACHETDP1ALOX5STAT3 | |
| Cumene Hydroperoxide SCHEMBL7524874 | 0.79 | ALDH1A1 (0.59) | ACHEKEAP1NFE2L2LMNATSHR | |
| SCHEMBL11781825 | 0.78 | ADRB2 (0.50) | TDP1LMNATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL17226284 | 0.78 | IDO1 (0.43) | ACHEALDH1A1 | |
| SCHEMBL10454546 | 0.77 | CHRNA7 (0.42) | CHRNA7ACHETDP1ALOX5LMNA | |
| SCHEMBL18800689 | 0.77 | HCAR2 (0.47) | LMNATSHRALOX12HSD17B10ALDH1A1 | |
| SCHEMBL297137 | 0.77 | HCAR2 (0.47) | LMNATSHRALOX12HSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5446227-A | Contacting alpha-methyl benzylic hydroperoxide with organic sulfide to produce corresponding hydroxide and oxygenated sulfur compound, treating hydroxide with base | PHILLIPS PETROLEUM COMPANY (US) | 1995-08-29 | — | — | US | claimed |
| US-11789363-B2 | Positive photosensitive resin composition, cured film therefrom, and solid state image sensor comprising the same | TORAY INDUSTRIES, INC. (JP) | 2023-10-17 | — | — | US | disclosed |
| US-20120064002-A1 | Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic Acid and Derivatives Thereof, Process for their Production and Use for the Production of Pharmaceutical Agents | LEHMANN LUTZ (DE) | 2012-03-15 | — | — | US | disclosed |
| EP-1494984-B1 | PROCESS FOR PREPARING PHENOLS | INEOS PHENOL GMBH & CO KG (DE) | 2007-09-12 | — | — | EP | disclosed |
| CN-1217902-C | Method for crackikng alkylaryl hydroperoxide | CARBOLIC ACID CHEMICAL CO LTD (DE) | 2005-09-07 | — | — | CN | disclosed |
| US-6875898-B2 | Process for preparing phenols | INEOS PHENOL GMBH & CO. KG (DE) | 2005-04-05 | — | — | US | disclosed |
| EP-1494984-A1 | PROCESS FOR PREPARING PHENOLS | INEOS Phenol GmbH & Co. KG (DE) | 2005-01-12 | — | — | EP | disclosed |
| EP-1366006-A1 | PROCESS FOR PREPARING PHENOLS | INEOS Phenol GmbH & Co. KG (DE) | 2003-12-03 | — | — | EP | disclosed |
| US-20030220528-A1 | Process for preparing phenols | BARCLAYS BANK PLC (IN ITS CAPACITY AS SECURITY TRUSTEE FOR ITSELF AND OTHER SECURED PARTIES) (GB) | 2003-11-27 | — | — | US | disclosed |
| WO-2003084909-A1 | PROCESS FOR PREPARING PHENOLS | INEOS PHENOL GMBH & CO. KG (DE) | 2003-10-16 | — | — | WO | disclosed |
| CN-1348944-A | Method for crackikng alkylaryl hydroperoxide | CARBOLIC ACID CHEMICAL CO LTD (DE) | 2002-05-15 | — | — | CN | disclosed |
| EP-1199295-A1 | Process for the cleavage of alkylaryl hydroperoxides | INEOS Phenol GmbH & Co. KG (DE) | 2002-04-24 | — | — | EP | disclosed |
| US-20020045781-A1 | Process for the cleavage of alkylaryl hydroperoxides | PHENOLCHEMIE GMBH & CO. KG (DE) | 2002-04-18 | — | — | US | disclosed |
| US-5446227-A | Contacting alpha-methyl benzylic hydroperoxide with organic sulfide to produce corresponding hydroxide and oxygenated sulfur compound, treating hydroxide with base | PHILLIPS PETROLEUM COMPANY (US) | 1995-08-29 | — | — | US | disclosed |
| EP-0032255-B1 | PROCESS FOR THE DIRECT NEUTRALISATION OF A REACTION MIXTURE RESULTING FROM THE ACID CLEAVAGE OF AN ALPHA-HYDROXY DERIVATIVE OF AN ALKYL-SUBSTITUTED AROMATIC HYDROCARBON AND THE REMOVAL OF THE FORMED SALT | UOP INC. (US) | 1984-03-14 | — | — | EP | disclosed |
| US-4333801-A | Recovery of a cumene/alpha-methylstyrene fraction from a mixture thereof with phenol and water | UOP INC. (US) | 1982-06-08 | — | — | US | disclosed |
| US-4299991-A | Formation of hydroperoxides | THE STANDARD OIL COMPANY (US) | 1981-11-10 | — | — | US | disclosed |
| EP-0032255-A1 | Process for the direct neutralisation of a reaction mixture resulting from the acid cleavage of an alpha-hydroxy derivative of an alkyl-substituted aromatic hydrocarbon and the removal of the formed salt | UOP INC. (US) | 1981-07-22 | — | — | EP | disclosed |
| US-4262151-A | Process for the recovery of phenol from a reaction mixture resulting from the acid cleavage of cumene hydroperoxide | UOP INC. (US) | 1981-04-14 | — | — | US | disclosed |
| US-3948995-A | Process for converting alkylaromatic hydroperoxides into phenolic products and carbonyl products | RHONE-POULENC-TEXTILE (FR) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120064002-A1 | Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic Acid and Derivatives Thereof, Process for their Production and Use for the Production of Pharmaceutical Agents | CYP4B1, CYP2B6, UGT2B7 | CHRNA7 267/4885ACHE 1629/4885TDP1 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.